OptimizeRx Named America’s Fastest-Growing Company for Fifth Year in a Row
April 11, 2024 07:30 ET
|
OptimizeRx Corporation
WALTHAM, Mass., April 11, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and...
OptimizeRx Sets Fourth Quarter 2023 Conference Call for March 28, 2024 at 8:30 a.m. ET
March 25, 2024 07:30 ET
|
OptimizeRx Corporation
WALTHAM, Mass., March 25, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), the leading provider of healthcare technology solutions helping life sciences companies reach and...
OptimizeRx Provides an Update on the Timing of Earnings Call and Reaffirms Prior Revenue and Adjusted EBITDA Estimates for FY2023
March 11, 2024 16:30 ET
|
OptimizeRx Corporation
WALTHAM, Mass., March 11, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), the leading provider of healthcare technology solutions helping life sciences companies reach and...
OptimizeRx Powers Walmart's ‘Specialty Pharmacies of the Community’ Outreach Effort
March 04, 2024 15:51 ET
|
OptimizeRx Corporation
WALTHAM, Mass., March 04, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and...
OptimizeRx to Participate in Upcoming Investor Conferences
February 21, 2024 07:30 ET
|
OptimizeRx Corporation
WALTHAM, Mass., Feb. 21, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), the leading provider of healthcare technology solutions helping life sciences companies reach and...
OptimizeRx Announces Strategic Board Changes to Support Growth and Evolving Landscape
January 25, 2024 07:30 ET
|
OptimizeRx Corporation
WALTHAM, Mass., Jan. 25, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and...
OptimizeRx Preannounces Select Expected 2023 Financials and Provides a Business Update
January 09, 2024 07:30 ET
|
OptimizeRx Corporation
WALTHAM, Mass., Jan. 09, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), the leading provider of healthcare technology solutions helping life sciences companies reach and...
OptimizeRx to Participate at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco
December 18, 2023 07:30 ET
|
OptimizeRx Corporation
WALTHAM, Mass., Dec. 18, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), the leading provider of healthcare technology solutions helping life sciences companies reach and...
OptimizeRx Reports Third Quarter 2023 Financial Results
November 06, 2023 07:00 ET
|
OptimizeRx Corporation
- Increases guidance for 2023 and introduces guidance for 2024- Total revenue of $16.3 million- GAAP net loss per share of $(0.17)- Non-GAAP net income per share of $0.09- Total DAAP (fka RWD) deals...
OptimizeRx Announces Completion of Medicx Acquisition and Sets Third Quarter 2023 Conference Call for November 6, 2023, at 8:30 a.m. ET
October 25, 2023 07:30 ET
|
OptimizeRx Corporation
WALTHAM, Mass., Oct. 25, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), the leading provider of healthcare technology solutions helping life sciences companies reach and...